InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the detailed record of transactions filed by Mayer Howard, 董事. Director active across 1 company, notably Entasis Therapeutics Holdings Inc.. In total, 2 reports have been published. Activity tracked since 18 January 2022. The latest transaction was disclosed on 7 July 2022 (U). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 条申报中的 2 条
Mayer Howard is a Director at Entasis Therapeutics Holdings Inc. In this role, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector allows him to provide valuable insights on industry issues. He collaborates with other board members to ensure the company's compliance and performance.